Columns
- All
- Advanced Degrees
- Analyze This
- Back Page
- Clinically Speaking
- Data Integrity
- Deal Discussions
- Editorial
- Emerging Markets
- Executive Perspective
- FDA Watch
- Financial Analysis
- Getting Results
- I Mak
- India Report
- Lowe Down
- Managing Your Career
- Newsmakers Interviews
- Opinions & Best Practices
- PBOA News
- Pharma Beat
- Preclinical Outsourcing
- The BioPharm Insider
-
Biologics, Proteins, Vaccines | Regulatory Affairs
What Will Change at FDA for 2021?
(R)evolution of the industry’s data, catalyzed by changes at FDA and what’s the likely impact to the pharmaceutical industry?Ben Locwin, Contributing Editor, International COVID-19 Advisor, Healthcare Futurist 04.01.21
-
Drug Delivery
The Ever-Evolving World of Combination Products
Looking at the benefits and challenges of the trend towards combination products.Ricki A. Chase, M.S, Lachman Consultants 04.01.21
-
Professional Etiquette at Two Critical Moments
Starting, or leaving, a job presents unique challenges.David G. Jensen, Contributing Editor 04.01.21
-
Regulatory Affairs
Post-Pandemic Regulations
Envisioning clinical development regulatory practices in a post-pandemic world.Ronan Brown, SVP and Head of Integrated Global Compliance, IQVIA 04.01.21
-
Information Technology
Life Sciences Strive for Greater Agility
Embracing real-time drug safety monitoring during and post COVID will continue to propel the industry forward.Ronan Brown and Joe Rymsza, IQVIA 03.01.21
-
Biologics, Proteins, Vaccines
Vaccines and Return-To-Normalcy
Planning for a future in which COVID-19 won’t simply ‘disappear.’Ben Locwin, Contributing Editor 03.01.21
-
Chemistry | Laboratory Testing
-
Stopping Career Burnout in Its Tracks
How to recognize and successfully combat—even avoid—burnout before it takes its toll.Ryan Raver, PhD, Contributing Editor 03.01.21
-
Aseptic Processing | Facilities | Fill/Finish | Parenterals
The Future of Pharmaceutical Manufacturing
Innovative multi-product facility and equipment design.Steve Nole, VP of Operations, Grand River Aseptic Manufacturing 01.27.21
-
Solid Dosage/Creams/Ointments
Recent Advances in Solid Dispersion Technologies
Improving the bioavailability and therapeutic efficiency of poorly soluble drugs.José L. Toro, Directory, Lachman Consultants 01.27.21
-
Biologics, Proteins, Vaccines
Vaccines 2021
Looking at the behavioral economics of vaccinations.Ben Locwin, Contributing Editor 01.27.21
-
The Art and Science of Recruitment
Chapter Four: Interview day and the importance of the hiring manager.David G. Jensen, Contributing Editor 01.27.21
-
The New (Ab)normal
Some lessons learned from the coronavirus pandemic of 2020 are likley to stay long-term.Tim Wright, Editor 01.27.21
-
Cell & Gene Therapy Supply Chain: Early Preparation is Key
Supply chain management for cell and gene therapies requires precise demand planning and forecasting.Matthew Farabaugh, Chief Financial Officer, The Discovery Labs 11.17.20
-
A Potential “Marriage”
Initiator companies and generics/CMOs working together.Emil W. Ciurczak, DoraMaxx Consulting 11.17.20
-
Injectables Firms Expand Capacity
CDMOs see steriles demand grow.S. Harachand, Contributing Editor 11.17.20
-
When Politics and Science Collide
COVID-19 illustrates why science should always be a principal informer of politics to make better and smarter decisions.Ben Locwin, Contributing Editor 11.17.20
-
The Importance of Hypothesis Testing During Investigations
Why it is critical to have controls in place during out-of-specification investigations to provide quality assurance.Paul Mason, PhD, Lachman Consultants 11.17.20
-
The Art and Science of Recruitment
Chapter Three: Landing the Best Candidate.David G. Jensen, Contributing Editor 11.17.20
-
Pfizer’s COVID-19 Vax Breakthrough
mRNA-based vaccine candidate found to have an efficacy rate above 90% in preventing COVID-19.Tim Wright, Editor 11.17.20
